UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 1, 2017

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 001-36743

Apple Inc.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

(408) 996-1010

(Registrant s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

5,213,840,000 shares of common stock, par value $0.00001 per share, issued and outstanding as of April 21, 2017

Apple Inc.

Form 10-Q

For the Fiscal Quarter Ended April 1, 2017

TABLE OF CONTENTS

Page

Part I

Item 1.

Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

23

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

32

Item 4.

Controls and Procedures

32

Part II

Item 1.

Legal Proceedings

33

Item 1A.

Risk Factors

33

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

43

Item 3.

Defaults Upon Senior Securities

43

Item 4.

Mine Safety Disclosures

43

Item 5.

Other Information

43

Item 6.

Exhibits

44

PART I FINANCIAL INFORMATION

Item 1.

Financial Statements

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

Six Months Ended

April 1,

2017

March 26,

2016

April 1,

2017

March 26,

2016

Net sales

52,896

50,557

131,247

126,429

Cost of sales

32,305

30,636

80,480

76,085

Gross margin

20,591

19,921

50,767

50,344

Operating expenses:

Research and development

2,776

2,511

5,647

4,915

Selling, general and administrative

3,718

3,423

7,664

7,271

Total operating expenses

6,494

5,934

13,311

12,186

Operating income

14,097

13,987

37,456

38,158

Other income/(expense), net

587

155

1,408

557

Income before provision for income taxes

14,684

14,142

38,864

38,715

Provision for income taxes

3,655

3,626

9,944

9,838

Net income

11,029

10,516

28,920

28,877

Earnings per share:

Basic

2.11

1.91

5.50

5.22

Diluted

2.10

1.90

5.46

5.19

Shares used in computing earnings per share:

Basic

5,225,791

5,514,381

5,262,226

5,536,656

Diluted

5,261,688

5,540,886

5,294,841

5,567,506

Cash dividends declared per share

0.57

0.52

1.14

1.04

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

Six Months Ended

April 1,

2017

March 26,

2016

April 1,

2017

March 26,

2016

Net income

11,029

10,516

28,920

28,877

Other comprehensive income/(loss):

Change in foreign currency translation, net of tax effects of $(44), $(19), $32 and $0, respectively

214

120

(161

18

Change in unrealized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax benefit/(expense) of $(25), $1, $(253) and $(37), respectively

(300

(178

1,168

109

Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $311, $144, $100 and $210, respectively

(1,032

(528

(726

(973

Total change in unrealized gains/losses on derivative instruments, net of tax

(1,332

(706

442

(864

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax benefit/(expense) of $(256), $(530), $733 and $(22), respectively

464

969

(1,344

47

Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $7, $(27), $(4) and $(53), respectively

(13

49

96

Total change in unrealized gains/losses on marketable securities, net of tax

451

1,018

(1,337

143

Total other comprehensive income/(loss)

(667

432

(1,056

(703

Total comprehensive income

10,362

10,948

27,864

28,174

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands and par value)

April 1,

2017

September 24,

2016

ASSETS:

Current assets:

Cash and cash equivalents

15,157

20,484

Short-term marketable securities

51,944

46,671

Accounts receivable, less an allowance of $53 at each period end

11,579

15,754

Inventories

2,910

2,132

Vendor non-trade receivables

9,033

13,545

Other current assets

11,367

8,283

Total current assets

101,990

106,869

Long-term marketable securities

189,740

170,430

Property, plant and equipment, net

27,163

27,010

Goodwill

5,473

5,414

Acquired intangible assets, net

2,617

3,206

Other non-current assets

7,549

8,757

Total assets

334,532

321,686

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

28,573

37,294

Accrued expenses

23,096

22,027

Deferred revenue

7,682

8,080

Commercial paper

9,992

8,105

Current portion of long-term debt

3,999

3,500

Total current liabilities

73,342

79,006

Deferred revenue, non-current

3,107

2,930

Long-term debt

84,531

75,427

Other non-current liabilities

39,470

36,074

Total liabilities

200,450

193,437

Commitments and contingencies

Shareholders equity:

Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,205,815 and 5,336,166 shares issued and outstanding, respectively

33,579

31,251

Retained earnings

100,925

96,364

Accumulated other comprehensive income/(loss)

(422

634

Total shareholders equity

134,082

128,249

Total liabilities and shareholders equity

334,532

321,686

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Six Months Ended

April 1,

2017

March 26,

2016

Cash and cash equivalents, beginning of the period

20,484

21,120

Operating activities:

Net income

28,920

28,877

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

5,319

5,431

Share-based compensation expense

2,473

2,126

Deferred income tax expense

2,822

3,092

Other

(209

308

Changes in operating assets and liabilities:

Accounts receivable, net

4,183

4,538

Inventories

(778

68

Vendor non-trade receivables

4,512

5,899

Other current and non-current assets

(896

186

Accounts payable

(6,862

(9,388

Deferred revenue

(221

219

Other current and non-current liabilities

316

(2,292

Cash generated by operating activities

39,579

39,064

Investing activities:

Purchases of marketable securities

(99,821

(86,242

Proceeds from maturities of marketable securities

12,429

9,148

Proceeds from sales of marketable securities

60,454

50,051

Payments made in connection with business acquisitions, net

(67

(140

Payments for acquisition of property, plant and equipment

(6,309

(5,948

Payments for acquisition of intangible assets

(126

(657

Payments for strategic investments

(126

Other

116

(196

Cash used in investing activities

(33,324

(34,110

Financing activities:

Proceeds from issuance of common stock

273

247

Excess tax benefits from equity awards

225

264

Payments for taxes related to net share settlement of equity awards

(788

(751

Payments for dividends and dividend equivalents

(6,134

(5,871

Repurchases of common stock

(18,012

(13,530

Proceeds from issuance of term debt, net

10,975

15,584

Change in commercial paper, net

1,879

(503

Cash used in financing activities

(11,582

(4,560

Increase/(Decrease) in cash and cash equivalents

(5,327

394

Cash and cash equivalents, end of the period

15,157

21,514

Supplemental cash flow disclosure:

Cash paid for income taxes, net

6,878

6,630

Cash paid for interest

1,007

565

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and markets mobile communication and media devices and personal computers, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company s products and services include iPhone , iPad , Mac , Apple Watch , Apple TV , a portfolio of consumer and professional software applications, iOS, macOS , watchOS and tvOS operating systems, iCloud , Apple Pay and a variety of accessory, service and support offerings. The Company sells and delivers digital content and applications through the iTunes Store , App Store , Mac App Store, TV App Store, iBooks Store and Apple Music (collectively Digital Content and Services ). The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party Apple-compatible products, including application software and various accessories through its retail and online stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 24, 2016 (the 2016 Form 10-K ).

The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2017 will include 53 weeks and ends on September 30, 2017 and its fiscal year 2016 included 52 weeks and ended on September 24, 2016. A 14th week was included in the first quarter of 2017, as is done every five or six years, to realign fiscal quarters with calendar quarters. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased by employees under the Company s employee stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended April 1, 2017 and March 26, 2016 (net income in millions and shares in thousands):

Three Months Ended

Six Months Ended

April 1,

2017

March 26,

2016

April 1,

2017

March 26,

2016

Numerator:

Net income

11,029

10,516

28,920

28,877

Denominator:

Weighted-average shares outstanding

5,225,791

5,514,381

5,262,226

5,536,656

Effect of dilutive securities

35,897

26,505

32,615

30,850

Weighted-average diluted shares

5,261,688

5,540,886

5,294,841

5,567,506

Basic earnings per share

2.11

1.91

5.50

5.22

Diluted earnings per share

2.10

1.90

5.46

5.19

Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities by significant investment category as of April 1, 2017 and September 24, 2016 (in millions):

April 1, 2017

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

7,600

7,600

7,600

Level 1 (1):

Money market funds

2,742

2,742

2,742

Mutual funds

997

(120

877

877

Subtotal

3,739

(120

3,619

2,742

877

Level 2 (2):

U.S. Treasury securities

53,365

65

(300

53,130

2,280

16,067

34,783

U.S. agency securities

5,680

(10

5,673

687

3,687

1,299

Non-U.S. government securities

7,151

135

(67

7,219

193

7,026

Certificates of deposit and time deposits

6,386

6,386

921

4,665

800

Commercial paper

3,233

3,233

877

2,356

Corporate securities

147,939

643

(449

148,133

50

23,992

124,091

Municipal securities

950

(3

950

77

873

Mortgage- and asset-backed securities

21,086

31

(219

20,898

30

20,868

Subtotal

245,790

880

(1,048

245,622

4,815

51,067

189,740

Total

257,129

880

(1,168

256,841

15,157

51,944

189,740

September 24, 2016

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

8,601

8,601

8,601

Level 1 (1):

Money market funds

3,666

3,666

3,666

Mutual funds

1,407

(146

1,261

1,261

Subtotal

5,073

(146

4,927

3,666

1,261

Level 2 (2):

U.S. Treasury securities

41,697

319

(4

42,012

1,527

13,492

26,993

U.S. agency securities

7,543

16

7,559

2,762

2,441

2,356

Non-U.S. government securities

7,609

259

(27

7,841

110

818

6,913

Certificates of deposit and time deposits

6,598

6,598

1,108

3,897

1,593

Commercial paper

7,433

7,433

2,468

4,965

Corporate securities

131,166

1,409

(206

132,369

242

19,599

112,528

Municipal securities

956

961

167

794

Mortgage- and asset-backed securities

19,134

178

(28

19,284

31

19,253

Subtotal

222,136

2,186

(265

224,057

8,217

45,410

170,430

Total

235,810

2,186

(411

237,585

20,484

46,671

170,430

(1)

Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.

(2)

Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company s long-term marketable securities generally range from one to five years.

The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. As of April 1, 2017, the Company does not consider any of its investments to be other-than-temporarily impaired.

Derivative Financial Instruments

The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.

To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges.

The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.

The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of April 1, 2017 are expected to be recognized within 10 years.

Cash Flow Hedges

The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions.

Net Investment Hedges

The effective portions of net investment hedges are recorded in other comprehensive income ( OCI ) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net.

Fair Value Hedges

Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item.

Non-Designated Derivatives

Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. As a result, during the three- and six-month periods ended April 1, 2017, respectively, the Company recognized a loss of $67 million and a gain of $206 million in net sales, a loss of $253 million and a gain of $79 million in cost of sales and a loss of $76 million and a gain of $432 million in other income/(expense), net.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company s derivative instruments at gross fair value as of April 1, 2017 and September 24, 2016 (in millions):

April 1, 2017

Fair Value of

Derivatives Designated

as Hedge Instruments

Fair Value of

Derivatives Not Designated

as Hedge Instruments

Total

Fair Value

Derivative assets (1):

Foreign exchange contracts

691

272

963

Interest rate contracts

161

161

Derivative liabilities (2):

Foreign exchange contracts

832

245

1,077

Interest rate contracts

354

354

10

September 24, 2016

Fair Value of

Derivatives Designated

as Hedge Instruments

Fair Value of

Derivatives Not Designated

as Hedge Instruments

Total

Fair Value

Derivative assets (1):

Foreign exchange contracts

518

153

671

Interest rate contracts

728